Oliceridine Versus Sufentanil on Hypoxemia Incidence During Sedated Gastrointestinal Endoscopy

NARecruitingINTERVENTIONAL
Enrollment

508

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

October 25, 2025

Study Completion Date

October 26, 2025

Conditions
Hypoxemia During SurgeryGastrointestinal Endoscopy
Interventions
DRUG

Oliceridine

Oliceridine will be administered intravenously at a dose of 1 mg for gastroscopy or 1.5 mg for colonoscopy, in combination with propofol (1-2 mg/kg), to provide sedation and analgesia during gastrointestinal endoscopy.

DRUG

Sufentanil

Sufentanil will be administered intravenously at a dose of 5 μg for gastroscopy or 7.5 μg for colonoscopy, in combination with propofol (1-2 mg/kg), to provide sedation and analgesia during gastrointestinal endoscopy.

Trial Locations (1)

431700

RECRUITING

Tianmen First People's Hospital, Tianmen

All Listed Sponsors
lead

Shiyou Wei

OTHER

NCT07187765 - Oliceridine Versus Sufentanil on Hypoxemia Incidence During Sedated Gastrointestinal Endoscopy | Biotech Hunter | Biotech Hunter